Unethical US research killed 83 in Guatemala: panel

by Diego Urdaneta

At least 83 people died as human guinea pigs in macabre US research on sexually transmitted diseases in Guatemala in the 1940s, a commission ordered by President Barack Obama concluded Monday.

Nearly 5,500 people were subjected to diagnostic testing and more than 1,300 were exposed to venereal diseases by human contact or inoculations in research meant to test the drug penicillin, the presidential commission found.

Within that group, "we believe that there were 83 deaths," said Stephen Hauser a member of the commission, which has pored over 125,000 documents linked to the shocking episode since being set up by Obama last November.

Among the 1,300 people exposed to STDs during research between 1946 and 1948, "under 700 received some form of treatment as best as could be documented," Hauser said.

Obama personally apologized to Guatemalan President Alvaro Colom in October before ordering a thorough review of what happened. Secretary of State Hillary Clinton described the experiments as "clearly unethical."

This sentiment was clearly expressed by the commission, which said US government researchers must have known they were contravening ethical standards by deliberately infecting mental patients with syphilis.

Commission president Amy Gutmann called it an "historic injustice," and said the inquiry aimed to "honor the victims and make sure it never happens again."

"It was not an accident that this happened in Guatemala," Gutmann said. "Some of the people involved said we could not do this in our own country."

The US researchers "systematically failed to act in accordance with minimal respect for human rights and morality in the conduct of research," she said, citing "substantial evidence" of an attempted cover-up.

A Guatemalan study, which was never published, came to light in 2010 after Wellesley College professor Susan Reverby stumbled upon archived documents outlining the experiment led by controversial US doctor John Cutler.

Cutler and his fellow researchers enrolled 1,500 people in Guatemala, including mental patients, for the study, which aimed to find out if penicillin could be used to prevent sexually transmitted diseases.

Initially, the researchers infected female Guatemalan commercial sex workers with gonorrhea or syphilis, and then encouraged them to have unprotected sex with soldiers or prison inmates.

Neither were the subjects told what the purpose of the research was nor were they warned of its potentially fatal consequences.

Cutler, who died in 2003, was also involved in a highly controversial study known as the Tuskegee Experiment in which hundreds of African-American men with late-stage syphilis were observed but given no treatment between 1932 and 1972.

The Guatemalan president has called the 1946-1948 experiments conducted by the US National Institutes of Health "crimes against humanity" and ordered his own investigation.

More information: Commission Website: http://www.bioethics.gov/

add to favorites email to friend print save as pdf

Related Stories

Guatemala STD study was 'wrong': US panel

Mar 01, 2011

The head of a bioethics commission convened by President Barack Obama said on Tuesday that a 1940s study of STDs using patients in Guatemala was wrong and that a US probe was continuing.

Guatemalans sue US over 1940s STD study

Mar 15, 2011

Seven Guatemalans filed a class action lawsuit in Washington over a 1940s US study in which hundreds of people in the Central American nation were deliberately infected with syphilis and gonorrhea without their consent.

Papers: Guatemalans welcomed US syphilis doctor

Mar 29, 2011

(AP) -- As U.S. doctors in Guatemala were wrapping up one of the most unethical medical experiments they had ever conducted, a Guatemalan medical official praised the lead researcher as noble and thanked him profusely.

US apologizes for '40s syphilis study in Guatemala

Oct 01, 2010

(AP) -- American scientists deliberately infected prisoners and patients in a mental hospital in Guatemala with syphilis 60 years ago, a recently unearthed experiment that prompted U.S. officials to apologize Friday and ...

Panel told no guarantee against unethical research

Mar 01, 2011

(AP) -- The nation has a "leaky system" for protecting patients in medical research, and it's possible - though unlikely - that the kind of unethical studies done in the past could occur again, bioethics experts told a presidential ...

Recommended for you

Hormonal therapy for transsexualism safe and effective

20 hours ago

Hormonal therapy for transsexual patients is safe and effective, a multicenter European study indicates. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Royalty Pharma lets Elan takeover bid expire

Jun 18, 2013

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

FDA approves new silicone breast implants

Jun 17, 2013

(HealthDay)—MemoryShape breast implants have been approved by the U.S. Food and Drug Administration for breast augmentation in women 22 and older, and for breast reconstruction, the FDA said Friday.

User comments

More news stories

Taxing unhealthy food spurs people to buy less

Labeling foods and beverages as less-healthy and taxing them motivates people to make healthier choices, finds a recent study in the American Journal of Preventive Medicine. When faced with a 30 percent tax on ...

Renewed hope in a once-abandoned cancer drug class

Could drugs that block the body's system for repairing damage to the genetic material DNA become a boon to health? As unlikely as it may seem, those compounds are sparking optimism as potential treatments ...

New technologies for retinal therapies

The future of the investigation and treatment of retinal disorders is already here at the MedUni Vienna: in the new Christian Doppler "OPTIMA" (Ophthalmic Image Analysis) laboratory headed by Ursula Schmidt-Erfurth, ...

Protalix signs supply deal with Brazilian govt

Shares of Protalix BioTherapeutics Inc. jumped in premarket trading Wednesday after the drug developer announced a deal that requires the Brazilian government to buy at least $280 million of the company's Gaucher disease ...

Laughing gas does not increase heart attacks

(Medical Xpress)—Nitrous oxide—best known as laughing gas—is one of the world's oldest and most widely used anesthetics. Despite its popularity, however, experts have questioned its impact on the risk ...